Search hospitals > Texas > San Antonio
Methodist Children's Hospital of South Texas
Claim this profileSan Antonio, Texas 78229
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Acute Lymphoblastic Leukemia
185 reported clinical trials
2 medical researchers
Summary
Methodist Children's Hospital of South Texas is a medical facility located in San Antonio, Texas. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Methodist Children's Hospital of South Texas is involved with conducting 185 clinical trials across 346 conditions. There are 2 research doctors associated with this hospital, such as Jose M. Esquilin and Vinod K. Gidvani-Diaz.Area of expertise
1Leukemia
Global LeaderStage II
t(8;21)(q22;q22) positive
t(16;16)(p13;q22) positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Jose M. EsquilinMethodist Children's Hospital of South Texas4 years of reported clinical research
Expert in Tumors
Expert in Cancer
47 reported clinical trials
102 drugs studied
Vinod K. Gidvani-DiazMethodist Children's Hospital of South Texas6 years of reported clinical research
Expert in Tumors
Expert in Lymphoma
41 reported clinical trials
100 drugs studied
Clinical Trials running at Methodist Children's Hospital of South Texas
Rhabdomyosarcoma
Osteosarcoma
Germ Cell Tumors
Acute Lymphoblastic Leukemia
Brain Tumor
Non-Hodgkin's Lymphoma
Leukemia
Lymphoma
Neuroblastoma
Lymphoblastic Leukemia-Lymphoma
Combination Chemotherapy
for Rhabdomyosarcoma
This study is evaluating whether a combination of chemotherapy drugs is more effective than a single chemotherapy drug for treating rhabdomyosarcoma.
Recruiting2 awards Phase 35 criteria
Chemotherapy
for Rhabdomyosarcoma
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma. Another aim of the study it to find out how well patients with low risk rhabdomyosarcoma (LR-RMS) respond to standard chemotherapy when patients with VLR-RMS and patients who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
Recruiting2 awards Phase 3
Genetic Testing-Directed Therapy
for Pediatric Cancer
This study is evaluating whether genetic testing may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Methodist Children's Hospital of South Texas?
Methodist Children's Hospital of South Texas is a medical facility located in San Antonio, Texas. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Methodist Children's Hospital of South Texas is involved with conducting 185 clinical trials across 346 conditions. There are 2 research doctors associated with this hospital, such as Jose M. Esquilin and Vinod K. Gidvani-Diaz.